0001209191-13-048153.txt : 20131011
0001209191-13-048153.hdr.sgml : 20131011
20131011141801
ACCESSION NUMBER: 0001209191-13-048153
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131011
FILED AS OF DATE: 20131011
DATE AS OF CHANGE: 20131011
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CymaBay Therapeutics, Inc.
CENTRAL INDEX KEY: 0001042074
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943103561
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
BUSINESS PHONE: 510-293-8800
MAIL ADDRESS:
STREET 1: 3876 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX, INC.
DATE OF NAME CHANGE: 20090721
FORMER COMPANY:
FORMER CONFORMED NAME: METABOLEX INC
DATE OF NAME CHANGE: 19970710
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
CENTRAL INDEX KEY: 0001280238
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55021
FILM NUMBER: 131147713
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 4050
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 4153624022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 4050
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
CENTRAL INDEX KEY: 0001280265
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55021
FILM NUMBER: 131147714
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 4153624022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
FORMER NAME:
FORMER CONFORMED NAME: ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
DATE OF NAME CHANGE: 20040213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ALTA BIOPHARMA PARTNERS III LP
CENTRAL INDEX KEY: 0001257444
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55021
FILM NUMBER: 131147715
BUSINESS ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 4153624022
MAIL ADDRESS:
STREET 1: ONE EMBARCADERO CENTER, SUITE 3700
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
3
1
doc3.xml
FORM 3 SUBMISSION
X0206
3
2013-10-11
0
0001042074
CymaBay Therapeutics, Inc.
NONE
0001257444
ALTA BIOPHARMA PARTNERS III LP
ONE EMBARCADERO CENTER
SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001280265
ALTA BIOPHARMA PARTNERS III GMBH & CO BETEILIGUNGS KG
ONE EMBARCADERO CENTER
SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
0001280238
ALTA EMBARCADERO BIOPHARMA PARTNERS III LLC
ONE EMBARCADERO CENTER
SUITE 3700
SAN FRANCISCO
CA
94111
0
0
1
0
Common Stock
64501
I
Alta BioPharma Partners III GmbH & Co. Beteiligungs KG
Common Stock
960433
D
Common Stock
23668
I
Alta Embarcadero BioPharma Partners III, LLC
Warrants (right to buy)
5.75
2013-09-30
2018-09-30
Common Stock
4613
I
Alta BioPharma Partners III GmbH & Co. Beteiligungs KG
Warrants (right to buy)
5.75
2013-09-30
2018-09-30
Common Stock
68693
D
Warrants (right to buy)
5.75
2013-09-30
2018-09-30
Common Stock
1692
I
Alta Embarcadero BioPharma Partners III, LLC
The securities are held by Alta BioPharma Partners III GmbH & Co. Beteiligungs KG ("ABP III KG"). Alta BioPharma Management Partners III, LLC ("ABMP") is the managing imited partner of ABP III KG. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
The securities are held by Alta BioPharma Partners III, L.P. ("ABP III"). ABMP is the general partner of ABP III. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
The securities are held by Alta Embarcadero BioPharma Partners III, LLC ("AEBP III"). ABMP is the manager of AEBP III. ABMP disclaims beneficial ownership of these securities except to the extent of any pecuniary interest therein.
/s/ Edward E. Penhoet
2013-10-11